OTCMKTS:PKPH Peak Pharmaceuticals (PKPH) Stock Price, News & Analysis $1.02 -0.13 (-11.30%) As of 05/30/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Peak Pharmaceuticals Stock (OTCMKTS:PKPH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Peak Pharmaceuticals alerts:Sign Up Key Stats Today's Range$1.02▼$2.1050-Day Range$1.15▼$6.1952-Week Range$0.52▼$9.12Volume2,745 shsAverage Volume9,053 shsMarket Capitalization$399,840.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPeak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.Read More… Receive PKPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address PKPH Stock News HeadlinesPeak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Down 31% - Here's WhyMay 28, 2025 | americanbankingnews.comAkari Therapeutics Merges with Peak Bio for GrowthNovember 9, 2024 | markets.businessinsider.com"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.June 1, 2025 | Crypto 101 Media (Ad)Netflix hit series Wednesday season 2 is a ‘cultural juggernaut’ that’s already breaking recordsNovember 4, 2024 | msn.comPhathom's Voquezna: A Breakthrough Drug Facing Marketing ChallengesSeptember 27, 2024 | seekingalpha.comThailand says mpox case recorded in traveller from AfricaAugust 22, 2024 | msn.comPharma stocks soar after WHO declares mpox public health emergencyAugust 20, 2024 | msn.comDaytime and early peak commissioningMay 2, 2024 | bbc.co.ukSee More Headlines PKPH Stock Analysis - Frequently Asked Questions How have PKPH shares performed this year? Peak Pharmaceuticals' stock was trading at $1.07 at the beginning of 2025. Since then, PKPH shares have decreased by 4.7% and is now trading at $1.02. View the best growth stocks for 2025 here. How do I buy shares of Peak Pharmaceuticals? Shares of PKPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Peak Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Peak Pharmaceuticals investors own include Ginkgo Bioworks (DNA), Jazz Pharmaceuticals (JAZZ), Medical Marijuana (MJNA), Altria Group (MO), OPKO Health (OPK), GrowLife (PHOT) and RTX (RTX). Company Calendar Today6/01/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryCannabis Current SymbolOTCMKTS:PKPH CIK1452804 Webwww.peakpharma.com Phone(480) 659-6404FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$160 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-159.55% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.15 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares392,000Free Float320,000Market Cap$399,840.00 OptionableNot Optionable Beta0.54 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (OTCMKTS:PKPH) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Peak Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
